Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV000563993 | SCV000672523 | likely benign | Hereditary cancer-predisposing syndrome | 2017-05-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV002528953 | SCV000768317 | likely benign | Familial adenomatous polyposis 1 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000563993 | SCV002532621 | likely benign | Hereditary cancer-predisposing syndrome | 2021-08-02 | criteria provided, single submitter | curation | |
All of Us Research Program, |
RCV004001096 | SCV004832755 | likely benign | Classic or attenuated familial adenomatous polyposis | 2023-06-26 | criteria provided, single submitter | clinical testing | |
Myriad Genetics, |
RCV002528953 | SCV004933004 | benign | Familial adenomatous polyposis 1 | 2024-03-27 | criteria provided, single submitter | clinical testing | This variant is considered benign. This variant is a silent/synonymous amino acid change and it is not expected to impact splicing. |
Color Diagnostics, |
RCV000563993 | SCV006064303 | likely benign | Hereditary cancer-predisposing syndrome | 2023-06-19 | criteria provided, single submitter | clinical testing |